Try our mobile app
Exhibit 99.1
Veritiv Announces Record Third Quarter 2022 Net Income, EPS, Adjusted EBITDA, and Adjusted EBITDA Margin; Initiates Quarterly Dividend; Raises 2022 Earnings Guidance
Third Quarter Financial Highlights
| • | Net sales of $1.8 Billion, an increase of 2.1% from prior year; organic sales growth of 14.9% |
| • | Net Income and Diluted EPS of $96.7 Million and $6.86, respectively |
| • | Adjusted EBITDA and Adjusted EBITDA Margin1 of $141.3 Million and 7.8%, respectively |
| • | Net Leverage Ratio of 0.6x |
Dividend Highlights
| • | Company is announcing today that the Board of Directors authorized a quarterly cash dividend of $0.63 per share |
| • | Annual dividend yield of approximately 2%, based on our recent share price |
| • | Initial dividend to be paid during fourth quarter 2022 |
ATLANTA (November 8, 2022) – Veritiv Corporation (NYSE: VRTV), a full-service provider of business-to-business products, services and solutions, today announced financial results for the third quarter ended September 30, 2022.
“Organic sales for the third quarter grew 15% fueled by a combination of above market volume performance in the U.S. corrugated and flexible Packaging businesses, pricing actions, and growth-oriented initiatives within key industry verticals,” said Sal Abbate, Chief Executive Officer. “Ongoing commercial and operational efficiency initiatives coupled with disciplined execution helped drive more than 50% year-over-year Adjusted EBITDA growth and our best Adjusted EBITDA margin performance across each of our segments for any quarter in company history. We believe our strategic actions over the past several years have fundamentally improved our business and positions us well to navigate the uncertain global economic environment.”
Abbate continued, “Today’s dividend announcement is the result of our fortified balance sheet and strong cash flow generation. Our improved and consistently strong financial performance and ongoing commercial and operational efficiency initiatives provide us with the confidence and flexibility to return excess capital to our shareholders while at the same time continuing to strategically invest in our business.”
For the three months ended September 30, 2022, compared to the three months ended September 30, 2021:
| • | Net sales were $1.8 billion, an increase of 2.1% from the prior year; organic sales increased 14.9%. |
| • | Net income was $96.7 million, compared to $40.0 million in the prior year. Net restructuring charges were $1.4 million, compared to $2.5 million in the prior year. |
| • | Basic and diluted earnings per share were $6.98 and $6.86, respectively, compared to $2.69 and $2.54, respectively, in the prior year. |
| • | Adjusted EBITDA was $141.3 million, an increase of 50.8% from the prior year. |
| • | Adjusted EBITDA margin was 7.8%, an increase of 250 basis points from the prior year. |
For the nine months ended September 30, 2022, compared to the nine months ended September 30, 2021:
| • | Net sales were $5.5 billion, an increase of 10.0% from the prior year; organic sales increased 17.9%. |
| • | Net income was $266.3 million, compared to $87.7 million in the prior year. Net restructuring charges were $5.5 million, compared to $12.0 million in the prior year. |
| • | Basic and diluted earnings per share were $18.49 and $18.04, respectively, compared to $5.68 and $5.40, respectively, in the prior year. |
| • | Adjusted EBITDA was $397.1 million, an increase of 75.2% from the prior year. |
| • | Adjusted EBITDA margin was 7.2%, an increase of 270 basis points from the prior year. |
For the three months ended September 30, 2022, net cash provided by operating activities was $96.6 million and free cash flow was $90.1 million. For the nine months ended September 30, 2022, net cash provided by operating activities was $158.9 million and free cash flow was $140.8 million.
“Our record earnings performance in the third quarter contributed to a record low net leverage ratio of 0.6x,” said Steve Smith, Chief Financial Officer. “We also completed our $200 million share repurchase program during the third quarter and repurchased 1.6 million shares over the course of this program, or approximately 10% of the shares outstanding. Since resuming share repurchases in March of 2021, we have repurchased approximately 3.3 million shares, or approximately 20% of the shares outstanding.”
Revised 2022 Guidance
Given the strong financial performance so far this year and favorable outlook for the remainder of the year, the Company now expects full year 2022 net income to be in the range of $320 to $340 million. Diluted earnings per share is estimated to be in the range of $22.00 to $23.50, based on approximately 14.5 million fully diluted shares outstanding. Adjusted EBITDA is now expected to be in the range of $510 to $530 million. Net cash provided by operating activities and free cash flow are still expected to be approximately $280 million and $250 million, respectively. Capital expenditures are still estimated to be approximately $30 million.
Quarterly Dividend
Veritiv Corporation’s Board of Directors approved a dividend of $0.63 per share payable on December 19, 2022 to shareholders of record as of the close of business on November 18, 2022.
1Adjusted EBITDA Margin is defined as Adjusted EBITDA as a percentage of net sales.
-----
Veritiv Corporation will host a conference call and webcast today, November 8, 2022, at 9 a.m. (ET) to discuss its third quarter financial results and full year 2022 guidance. To participate, callers within the United States (U.S.) and Canada can dial (888) 330-2469, and international callers can use the following link for international access numbers, https://events.evolveirportal.com/custom/access/2324, both using conference ID number 3047006. Interested parties can also listen online at ir.veritivcorp.com. A replay of the call and webcast will be available online for a limited period of time at ir.veritivcorp.com shortly after the webcast is completed.
Important information regarding U.S. generally accepted accounting principles (“U.S. GAAP”) and related reconciliations of non-GAAP financial measures to the most comparable U.S. GAAP measures can be found in the schedules to this press release, which should be thoroughly reviewed.
About Veritiv
Veritiv Corporation (NYSE: VRTV), headquartered in Atlanta and a Fortune 500® company, is a full-service provider of packaging, JanSan and hygiene products, services and solutions. Additionally, Veritiv provides print and publishing products. Serving customers in a wide range of industries both in North America and globally, Veritiv has distribution centers throughout the U.S. and Mexico, and team members around the world helping shape the success of its customers. For more information about Veritiv and its business segments visit www.veritivcorp.com.
Safe Harbor Provision
Certain statements contained in this press release regarding Veritiv Corporation’s (the “Company”) future operating results, performance, strategy, business plans, prospects and guidance, statements related to the impact of COVID-19 and any other statements not constituting historical fact are “forward-looking statements” subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Where possible, the words “believe,” “expect,” “anticipate,” “continue,” “intend,” “should,” “will,” “would,” “planned,” “estimated,” “potential,” “goal,” “outlook,” “may,” “predicts,” “could,” or the negative of such terms, or other comparable expressions, have been used to identify such forward-looking statements. All forward-looking statements reflect only the Company’s current beliefs and assumptions with respect to future operating results, performance, business plans, prospects, guidance and other matters, and are based on information currently available to the Company. Accordingly, the statements are subject to significant risks, uncertainties and contingencies, which could cause the Company’s actual operating results, performance, business plans, prospects or guidance to differ materially from those expressed in, or implied by, these statements.
Factors that could cause actual results to differ materially from current expectations include the risks and other factors described under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and in the Company’s other publicly available reports filed with the Securities and Exchange Commission (“SEC”). Such risks and other factors, which in some instances are beyond the Company’s control, include: adverse impacts of the COVID-19 pandemic; the industry-wide decline in demand for paper and related products; increased competition from existing and non-traditional sources; procurement and other risks in obtaining packaging, facility products and paper from our suppliers for resale to our customers; changes in prices for raw materials; changes in trade policies and regulations; increases in the cost of fuel and third-party freight and the availability of third-party freight providers; the loss of any of our significant customers; inability to realize expected benefits of restructuring plans; adverse developments in general business and economic conditions that could impair our ability to use net operating loss carryforwards and other deferred tax assets; our ability to adequately protect our material intellectual property and other proprietary rights, or to defend successfully against intellectual property infringement claims by third parties; our ability to attract, train and retain highly qualified employees; our pension and health care costs and participation in multi-employer pension, health and welfare plans; the effects of work stoppages, union negotiations and labor disputes; our ability to generate sufficient cash to service our debt; increasing interest rates; our ability to refinance or restructure our debt on reasonable terms and conditions as might be necessary from time to time; our ability to comply with the covenants contained in our debt agreements; costs to comply with laws, rules and regulations, including environmental, health and safety laws, and to satisfy any liability or obligation imposed under such laws; changes in tax laws; adverse results from litigation, governmental investigations or audits, or tax-related proceedings or audits; regulatory changes and judicial rulings impacting our business; the impact of adverse developments in general business and economic conditions as well as conditions in the global capital and credit markets on demand for our products and services, our business including our international operations, and our customers; foreign currency fluctuations; inclement weather, widespread outbreak of an illness, anti-terrorism measures and other disruptions to our supply chain, distribution system and operations; our dependence on a variety of information technology and telecommunications systems and the Internet; our reliance on third-party vendors for various services; cybersecurity risks; and other events of which we are presently unaware or that we currently deem immaterial that may result in unexpected adverse operating results.
The Company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet service providers. This press release is being furnished to the SEC through a Form 8-K. The Company’s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2022 to be filed with the SEC may contain updates to the information included in this release.
Financial Statements
VERITIV CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data, unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Net sales | $ | 1,804.1 | $ | 1,767.8 | $ | 5,482.9 | $ | 4,985.7 | ||||||||
| Cost of products sold (exclusive of depreciation and amortization shown separately below) | 1,388.3 | 1,402.1 | 4,254.6 | 3,959.2 | ||||||||||||
| Distribution expenses | 93.4 | 103.4 | 303.8 | 308.9 | ||||||||||||
| Selling and administrative expenses | 194.9 | 189.7 | 573.5 | 537.0 | ||||||||||||
| Gain on sale of businesses | (18.6 | ) | — | (28.6 | ) | (3.1 | ) | |||||||||
| Depreciation and amortization | 10.8 | 13.3 | 34.6 | 42.1 | ||||||||||||
| Restructuring charges, net | 1.4 | 2.5 | 5.5 | 12.0 | ||||||||||||
| Operating income (loss) | 133.9 | 56.8 | 339.5 | 129.6 | ||||||||||||
| Interest expense, net | 4.8 | 3.8 | 12.3 | 13.4 | ||||||||||||
| Other (income) expense, net | 0.0 | (1.1 | ) | (7.2 | ) | (3.8 | ) | |||||||||
| Income (loss) before income taxes | 129.1 | 54.1 | 334.4 | 120.0 | ||||||||||||
| Income tax expense (benefit) | 32.4 | 14.1 | 68.1 | 32.3 | ||||||||||||
| Net income (loss) | $ | 96.7 | $ | 40.0 | $ | 266.3 | $ | 87.7 | ||||||||
| Earnings (loss) per share: | ||||||||||||||||
| Basic | $ | 6.98 | $ | 2.69 | $ | 18.49 | $ | 5.68 | ||||||||
| Diluted | $ | 6.86 | $ | 2.54 | $ | 18.04 | $ | 5.40 | ||||||||
| Weighted-average shares outstanding: | ||||||||||||||||
| Basic | 13.85 | 14.86 | 14.40 | 15.44 | ||||||||||||
| Diluted | 14.10 | 15.76 | 14.76 | 16.24 | ||||||||||||
VERITIV CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in millions, except par value, unaudited)
| September 30, 2022 | December 31, 2021 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 33.8 | $ | 49.3 | ||||
| Accounts receivable, less allowances of $28.6 and $34.4, respectively | 962.3 | 1,011.2 | ||||||
| Inventories | 449.2 | 484.5 | ||||||
| Other current assets | 138.7 | 132.7 | ||||||
| Total current assets | 1,584.0 | 1,677.7 | ||||||
| Property and equipment (net of accumulated depreciation and amortization of $317.8 and $332.4, respectively) | 131.3 | 162.9 | ||||||
| Goodwill | 96.3 | 99.6 | ||||||
| Other intangibles, net | 36.7 | 42.7 | ||||||
| Deferred income tax assets | 53.8 | 47.1 | ||||||
| Other non-current assets | 337.5 | 408.4 | ||||||
| Total assets | $ | 2,239.6 | $ | 2,438.4 | ||||
| Liabilities and shareholders’ equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 543.2 | $ | 561.9 | ||||
| Accrued payroll and benefits | 84.9 | 110.0 | ||||||
| Other accrued liabilities | 157.7 | 185.7 | ||||||
| Current portion of debt | 13.8 | 16.0 | ||||||
| Total current liabilities | 799.6 | 873.6 | ||||||
| Long-term debt, net of current portion | 389.9 | 499.7 | ||||||
| Defined benefit pension obligations | 4.2 | 7.2 | ||||||
| Other non-current liabilities | 360.8 | 422.1 | ||||||
| Total liabilities | 1,554.5 | 1,802.6 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders’ equity: | ||||||||
| Preferred stock, $0.01 par value, 10.0 million shares authorized, none issued | — | — | ||||||
| Common stock, $0.01 par value, 100.0 million shares authorized; shares issued - 17.5 million and 17.0 million, respectively; shares outstanding - 13.5 million and 14.6 million, respectively | 0.2 | 0.2 | ||||||
| Additional paid-in capital | 611.5 | 633.8 | ||||||
| Accumulated earnings (deficit) | 409.5 | 143.2 | ||||||
| Accumulated other comprehensive loss | (19.0 | ) | (24.3 | ) | ||||
| Treasury stock at cost - 4.0 million and 2.4 million shares, respectively | (317.1 | ) | (117.1 | ) | ||||
| Total shareholders’ equity | 685.1 | 635.8 | ||||||
| Total liabilities and shareholders’ equity | $ | 2,239.6 | $ | 2,438.4 | ||||
VERITIV CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions, unaudited)
| Nine Months Ended September 30, | ||||||||
| 2022 | 2021 | |||||||
| Operating activities | ||||||||
| Net income (loss) | $ | 266.3 | $ | 87.7 | ||||
| Depreciation and amortization | 34.6 | 42.1 | ||||||
| Amortization and write-off of deferred financing fees | 1.2 | 1.1 | ||||||
| Net (gains) losses on disposition of assets and sale of businesses | (33.7 | ) | (9.1 | ) | ||||
| Provision for expected credit losses | 2.6 | 4.6 | ||||||
| Deferred income tax provision (benefit) | (6.7 | ) | (0.3 | ) | ||||
| Stock-based compensation | 7.7 | 5.7 | ||||||
| Other non-cash items, net | (7.5 | ) | 1.3 | |||||
| Changes in operating assets and liabilities | ||||||||
| Accounts receivable | (66.1 | ) | (120.1 | ) | ||||
| Inventories | (51.5 | ) | (20.4 | ) | ||||
| Other current assets | (5.5 | ) | (5.8 | ) | ||||
| Accounts payable | 40.5 | 97.7 | ||||||
| Accrued payroll and benefits | (19.0 | ) | 10.3 | |||||
| Other accrued liabilities | (1.3 | ) | (11.6 | ) | ||||
| Other | (2.7 | ) | 8.4 | |||||
| Net cash provided by (used for) operating activities | 158.9 | 91.6 | ||||||
| Investing activities | ||||||||
| Property and equipment additions | (18.1 | ) | (14.1 | ) | ||||
| Proceeds from asset sales and sale of businesses, net of cash transferred | 158.2 | 15.8 | ||||||
| Proceeds from insurance related to property and equipment | 3.3 | — | ||||||
| Net cash provided by (used for) investing activities | 143.4 | 1.7 | ||||||
| Financing activities | ||||||||
| Change in book overdrafts | 12.3 | (0.9 | ) | |||||
| Borrowings of long-term debt | 4,713.1 | 4,353.6 | ||||||
| Repayments of long-term debt | (4,799.4 | ) | (4,401.1 | ) | ||||
| Payments under right-of-use finance leases | (9.1 | ) | (10.2 | ) | ||||
| Payments under vendor-based financing arrangements | (3.2 | ) | — | |||||
| Deferred financing fees | — | (3.3 | ) | |||||
| Purchase of treasury stock | (200.0 | ) | (100.0 | ) | ||||
| Impact of tax withholding on share-based compensation | (30.0 | ) | (8.4 | ) | ||||
| Other | (0.2 | ) | 0.2 | |||||
| Net cash provided by (used for) financing activities | (316.5 | ) | (170.1 | ) | ||||
| Effect of exchange rate changes on cash | (1.3 | ) | (0.4 | ) | ||||
| Net change in cash and cash equivalents | (15.5 | ) | (77.2 | ) | ||||
| Cash and cash equivalents at beginning of period | 49.3 | 120.6 | ||||||
| Cash and cash equivalents at end of period | $ | 33.8 | $ | 43.4 | ||||
| Supplemental cash flow information | ||||||||
| Cash paid for income taxes, net of refunds | $ | 78.7 | $ | 37.2 | ||||
| Cash paid for interest | 10.7 | 11.9 | ||||||
| Non-cash investing and financing activities | ||||||||
| Non-cash additions to property and equipment for right-of-use finance leases and vendor-based financing arrangements | $ | 18.6 | $ | 1.9 | ||||
| Non-cash additions to other non-current assets for right-of-use operating leases | 38.7 | 59.3 | ||||||
Non-GAAP Measures
We supplement our financial information prepared in accordance with U.S. GAAP with certain non-GAAP measures including organic sales (net sales on an average daily sales basis, excluding revenue from sold businesses and revenue from acquired businesses for a period of 12 months after we complete the acquisition), Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, restructuring charges, net, integration and acquisition expenses and other similar charges including any severance costs, costs associated with warehouse and office openings or closings, consolidation, and relocation and other business optimization expenses, stock-based compensation expense, changes in the LIFO reserve, non-restructuring asset impairment charges, non-restructuring severance charges, non-restructuring pension charges (benefits), fair value adjustments related to contingent liabilities assumed in mergers and acquisitions and certain other adjustments), free cash flow and other non-GAAP measures such as the Net Leverage Ratio (calculated as net debt divided by trailing twelve months of Adjusted EBITDA) and Return on Invested Capital (calculated as Net Operating Profit After Tax divided by the sum of net working capital and property and equipment. Net Operating Profit After Tax is defined as Adjusted EBITDA less depreciation and amortization times 1 minus the standard tax rate1). We believe investors commonly use Adjusted EBITDA, free cash flow and these other non-GAAP measures as key financial metrics for valuing companies; we also present organic sales to help investors better compare period-over-period results. In addition, the credit agreement governing our Asset-Based Lending Facility (the “ABL Facility”) permits us to exclude the foregoing and other charges in calculating “Consolidated EBITDA”, as defined in the ABL Facility.
Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures are not alternative measures of financial performance or liquidity under U.S. GAAP. Non-GAAP measures do not have definitions under U.S. GAAP and may be defined differently by, and not be comparable to, similarly titled measures used by other companies. As a result, we consider and evaluate non-GAAP measures in connection with a review of the most directly comparable measure calculated in accordance with U.S. GAAP. We caution investors not to place undue reliance on such non-GAAP measures and to consider them with the most directly comparable U.S. GAAP measures. Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Please see the following tables for reconciliations of non-GAAP measures to the most comparable U.S. GAAP measures.
1 The Company uses a standard tax rate of 26% due to the historic volatility of the Company’s effective tax rate.
Table I
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
NET INCOME (LOSS) TO ADJUSTED EBITDA; ADJUSTED EBITDA MARGIN
(in millions, unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Net income (loss) | $ | 96.7 | $ | 40.0 | $ | 266.3 | $ | 87.7 | ||||||||
| Interest expense, net | 4.8 | 3.8 | 12.3 | 13.4 | ||||||||||||
| Income tax expense (benefit) | 32.4 | 14.1 | 68.1 | 32.3 | ||||||||||||
| Depreciation and amortization | 10.8 | 13.3 | 34.6 | 42.1 | ||||||||||||
| EBITDA | 144.7 | 71.2 | 381.3 | 175.5 | ||||||||||||
| Restructuring charges, net | 1.4 | 2.5 | 5.5 | 12.0 | ||||||||||||
| Gain on sale of businesses | (18.6 | ) | — | (28.6 | ) | (3.1 | ) | |||||||||
| Facility closure charges, including (gain) loss from asset disposition | 1.9 | 0.2 | 1.0 | (1.0 | ) | |||||||||||
| Stock-based compensation | 1.8 | 1.0 | 7.7 | 5.7 | ||||||||||||
| LIFO reserve (decrease) increase | 7.3 | 15.1 | 30.1 | 31.2 | ||||||||||||
| Non-restructuring severance charges | 0.5 | 3.6 | 2.0 | 5.5 | ||||||||||||
| Non-restructuring pension charges (benefits) | — | — | (7.0 | ) | — | |||||||||||
| Other | 2.3 | 0.1 | 5.1 | 0.9 | ||||||||||||
| Adjusted EBITDA | $ | 141.3 | $ | 93.7 | $ | 397.1 | $ | 226.7 | ||||||||
| Net sales | $ | 1,804.1 | $ | 1,767.8 | $ | 5,482.9 | $ | 4,985.7 | ||||||||
| Adjusted EBITDA as a % of net sales | 7.8 | % | 5.3 | % | 7.2 | % | 4.5 | % | ||||||||
Table I.a.
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
ADJUSTED EBITDA GUIDANCE
(in millions, unaudited)
| Forecast for Year Ending December 31, 2022 | ||||||||
| Low | High | |||||||
| Net income (loss) | $ | 320 | $ | 340 | ||||
| Interest expense, net | 15 | 15 | ||||||
| Income tax expense (benefit) | 95 | 100 | ||||||
| Depreciation and amortization | 45 | 45 | ||||||
| Other reconciling items | 35 | 30 | ||||||
| Adjusted EBITDA | $ | 510 | $ | 530 | ||||
Table II
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
FREE CASH FLOW
(in millions, unaudited)
| Three Months Ended September 30, 2022 | Nine Months Ended September 30, 2022 | |||||||
| Net cash provided by (used for) operating activities | $ | 96.6 | $ | 158.9 | ||||
| Less: Capital expenditures | (6.5 | ) | (18.1 | ) | ||||
| Free cash flow | $ | 90.1 | $ | 140.8 | ||||
Table II.a
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
FREE CASH FLOW GUIDANCE
(in millions, unaudited)
| Forecast for Year Ending December 31, 2022 | ||||
| Net cash provided by (used for) operating activities | approximately $280 | |||
| Less: Capital expenditures | approximately ($30 | ) | ||
| Free cash flow | approximately $250 |
Table III
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
NET DEBT TO ADJUSTED EBITDA
(in millions, unaudited)
| September 30, 2022 | ||||
| Amount drawn on ABL Facility | $ | 354.5 | ||
| Less: Cash and cash equivalents | (33.8 | ) | ||
| Net debt | $ | 320.7 | ||
| Last Twelve Months Adjusted EBITDA | $ | 513.0 | ||
| Net debt to Adjusted EBITDA | 0.6 | x | ||
| Last Twelve Months | ||||
| September 30, 2022 | ||||
| Net income (loss) | $ | 323.2 | ||
| Interest expense, net | 16.1 | |||
| Income tax expense (benefit) | 88.7 | |||
| Depreciation and amortization | 47.7 | |||
| EBITDA | 475.7 | |||
| Restructuring charges, net | 8.9 | |||
| Gain on sale of businesses | (28.6 | ) | ||
| Facility closure charges, including (gain) loss from asset disposition | 2.1 | |||
| Stock-based compensation | 9.4 | |||
| LIFO reserve (decrease) increase | 42.5 | |||
| Non-restructuring severance charges | 4.3 | |||
| Non-restructuring pension charges (benefits) | (6.5 | ) | ||
| Other | 5.2 | |||
| Adjusted EBITDA | $ | 513.0 | ||
Table IV
VERITIV CORPORATION
RECONCILIATION OF NON-GAAP MEASURES
REPORTED SALES GROWTH TO ORGANIC SALES GROWTH
(in millions, unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Reported sales growth | 2.1 | % | 11.1 | % | 10.0 | % | 6.0 | % | ||||||||
| Impact of change in selling days1 | — | % | — | % | — | % | 0.6 | % | ||||||||
| Sales per day growth | 2.1 | % | 11.1 | % | 10.0 | % | 6.6 | % | ||||||||
| Business divestitures2 | 12.8 | % | 1.5 | % | 7.9 | % | (0.3 | )% | ||||||||
| Organic sales growth | 14.9 | % | 12.6 | % | 17.9 | % | 6.3 | % | ||||||||
| Business Days | 64 | 64 | 191 | 191 | ||||||||||||
| 1 Adjustment for differences in the number of selling days. |
| 2 Represents the net sales of each of the following divested businesses prior to its respective divestiture: Rollsource (March 31, 2021), Veritiv Canada, Inc. (May 2, 2022) and the logistics solutions business (September 1, 2022). |
Veritiv Contacts:
| Investors: Scott Palfreeman, 844-845-2136 | Media: Kristie Madara, 770-391-8471 |
